SSRIs, SNRIs, and Pregnancy: Reassuring Data on Neurodevelopmental Outcomes
A large meta-analysis finds no causal link between prenatal antidepressant exposure and neurodevelopmental disorders after accounting for confounding factors.
Pharmacologic Treatment of Postpartum Depression: What Happens in the Real World?
New data reveal that while most women with postpartum depression start antidepressant treatment, many discontinue treatment early—highlighting persistent gaps in postpartum care.
Beyond the FDA Panel: Medical Experts Reaffirm the Safety and Essential Role of SSRIs for Perinatal Mental Health
The recent FDA expert panel focused largely on the risks of SSRIs during pregnancy; however, medical organizations and experts support the important role of SSRIs and other medications in supporting maternal mental health.
Marlene Freeman, MD: Getting to the Truth About SSRIs and Pregnancy (Video)
The recent FDA expert panel focused largely on the risks of SSRIs during pregnancy; Dr. Freeman weighs in on the information provided in the report.
Information for Patients: How to Interpret the Recent FDA Panel on SSRIs and Pregnancy
The recent FDA expert panel focused largely on the risks of SSRIs during pregnancy but ignored or diminished the risks associated with untreated depression in the mother.Â
Weighing the Evidence: Response to the FDA’s Recent Panel on Antidepressant Use in Pregnancy.
The recent FDA expert panel focused largely on the risks of SSRIs during pregnancy but ignored or diminished the risks associated with untreated depression in the mother.Â
Using AI and Data from the Medical Record to Identify Individuals at Risk for Postpartum Depression
In a recent study from Mass General Hospital, researchers examined whether information included in the medical record at the time of discharge after delivery could help us to identify individuals at increased risk for postpartum depression.
Postpartum Depression with Comorbid Anxiety: Optimizing Treatment
Postpartum anxiety is a common and often under-recognized condition that affects a substantial proportion of new mothers.
Another Study on Antidepressants and Birth Defects: Does it Change Our Decision-Making?
Prozac (fluoxetine) was the first SSRI or selective serotonin reuptake inhibitor. Since its release in 1988, we have been gathering data on the reproductive safety of fluoxetine and other SSRIs. Over the last 32 years, [...]
Ovarian Suppression for PMDD: New Study Suggests Long-Term Effectiveness and Tolerability
PMDD or premenstrual dysphoric disorder has always been a bit of mystery. Â We explain that PMDD is triggered by changes in reproductive hormone levels, but when you look at hormone levels in women with PMDD, [...]